GSK3B and acute respiratory distress syndrome: Others non-ATP competitive inhibitors of GSK3β such as benzothiazepinones derivatives 3j and 6j highly attenuate in vivo the LPS (E. coli O55:B5)-induced acute lung injury (ALI) and diminish inflammation response in mice by inhibiting the IL-1β and IL-6 expression (56).